Ying Wang
Impact in
- Genetics top 0.05%
- Mesenchymal stem cell research
- Immunology top 0.1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Epigenetics and DNA Methylation 32
- Oncology 205
- Cancer Immunotherapy and Biomarkers 46
- CAR-T cell therapy research 43
- Co-authors
- Yufang Shi (70 shared papers)Wei Cao (8 shared papers)Liangyu Lin (20 shared papers)Changshun Shao (19 shared papers)Keli Liu (10 shared papers)Michelle Wehling‐Henricks (7 shared papers)James G. Tidball (7 shared papers)Liming Du (12 shared papers)
- Journals
- PLoS ONE (23 papers)Frontiers in Immunology (19 papers)Blood (17 papers)The Journal of Immunology (16 papers)Cell Death and Disease (13 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ying Wang
914 papers receiving 33.7k citations
Ying Wang's Hit Papers
Peers
Comparison fields: 5 of 197
- Genetics 4.3k
- Immunology 7.0k
- Oncology 6.5k
- Cancer Research 3.5k
- Molecular Biology 12.5k
Countries citing papers authored by Ying Wang
This map shows the geographic impact of Ying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Wang more than expected).
Fields of papers citing papers by Ying Wang
This network shows the impact of papers produced by Ying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Wang. The network helps show where Ying Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 963 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications Hit paper breakdown → | 2014 | 1130 |
| 2 | PD-L1 Expression in Triple-Negative Breast Cancer Hit paper breakdown → | 2014 | 1089 |
| 3 | Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Hit paper breakdown → | 2016 | 975 |
| 4 | Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases Hit paper breakdown → | 2018 | 873 |
| 5 | The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development Hit paper breakdown → | 2007 | 605 |
| 6 | Immunobiology of mesenchymal stem cells Hit paper breakdown → | 2013 | 602 |
| 7 | New horizons in tumor microenvironment biology: challenges and opportunities Hit paper breakdown → | 2015 | 552 |
| 8 | The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC Hit paper breakdown → | 2019 | 418 |
| 9 | 2012 | 379 | |
| 10 | Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets Hit paper breakdown → | 2016 | 379 |
| 11 | 2015 | 353 | |
| 12 | Base editing with a Cpf1–cytidine deaminase fusion Hit paper breakdown → | 2018 | 324 |
| 13 | 2008 | 320 | |
| 14 | 2012 | 299 | |
| 15 | 2004 | 293 | |
| 16 | PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions Hit paper breakdown → | 2019 | 291 |
| 17 | 1999 | 290 | |
| 18 | 2017 | 280 | |
| 19 | The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice Hit paper breakdown → | 2021 | 238 |
| 20 | 2014 | 230 |
About Ying Wang
Ying Wang is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Surgery, having authored 963 papers that have together received 34.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (76 papers), Immunotherapy and Immune Responses (65 papers), Mesenchymal stem cell research (51 papers), Cancer Immunotherapy and Biomarkers (46 papers), CAR-T cell therapy research (43 papers), T-cell and B-cell Immunology (42 papers), Immune cells in cancer (35 papers) and Epigenetics and DNA Methylation (32 papers). The work is most often cited by research in Genetics (4.3k citations), Immunology (7.0k citations), Oncology (6.5k citations), Cancer Research (3.5k citations) and Molecular Biology (12.5k citations). Ying Wang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yufang Shi, Wei Cao, Liangyu Lin, Changshun Shao, Keli Liu, Michelle Wehling‐Henricks, James G. Tidball, Liming Du, Liliang Xia and Pengfei Yu. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Blood, The Journal of Immunology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.